JIM Today 2018 - Friday - page 7

Issue 2 
Friday
 23 February 2018 
JIM today
7
Mitral valve replacement ready for prime time?
B
ernard Prendergast is a consultant cardiolo-
gist based in London, UK. He has an inter-
national reputation for tackling heart valve
disease and is based at St Thomas’ Hospital, which
has one of the largest TAVI services, and recently
completed its thousandth TAVI procedure. He is
also Director of PCR London Valves, the world’s
largest meeting dedicated to valve disease.
Dr Prendergast will be speaking during this
afternoon’s ‘Structural Heart 2’ session, where he
will argue that mitral valve replacement is now
“ready for prime time”. He spoke to
JIM Today
to
outline the main messages he hopes to share with
the audience.
What is the crux of your talk?
I will be talking about transcatheter valve replace-
ment, not repair, in the mitral position. It’s a
potentially large clinical field that we are moving
into in terms of the numbers of patients. But there
have been some difficulties along the road so
far, in terms of the challenges that these patients
present. I will be talking briefly about the range of
different devices currently available and the clinical
literature, which is quite limited. I’ll be offering,
I suppose, a bit of philosophy about where it’s
all heading.
Has there been much uptake of mitral valve
replacement?
We are not seeing very large numbers. That’s one
of the paradoxes. The number of patients with
mitral regurgitation is potentially very large, but the
challenge we face is that the mitral valve is a much
more complicated entity than the aortic valve. I
Structural Heart 2 
Porta 
Friday 
12:45
“I will be talking briefly
about the range of
different devices currently
available and the clinical
literature, which is quite
limited. I’ll be offering,
I suppose, a bit of
philosophy about where it’s
all heading.”
Bernard Prendergast
Continued on page 8
1,2,3,4,5,6 8,9,10,11,12,13,14,15,16,17,...20
Powered by FlippingBook